Overexpression of MIF has been reported in several cancer types, including lung cancer, and is associated with tumor progression, metastasis, and poor prognosis (Verjans et al., 2009; Nobre et al., 2017; Penticuff et al., 2019). This evidence concerns the gene MIF and lung carcinoma.